8/4/2021NMPA Reportedly Seeking Comments on Proposed Regulation of Online Drug...

8/3/2021Burning Rock and IMPACT Therapeutics Announce a Global Partnership for...

8/3/2021WuXi STA Completes Acquisition of BMS Manufacturing Facility in Couvet...

8/2/2021SMEI: Chinese Retail Pharmacy Market (Offline and Online) Rose 12.5% i...

8/2/2021SMEI Predicts Restructure of Chinese Drug Retail Market and Further Bo...

8/2/2021Eisai's Anti-Epileptic Fycompa Approved in China as Monotherapy for Pa...

8/2/2021WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Cert...

8/2/2021Chinese Biosimilars Surge between 2018 and 2020 Due to New NMPA Regula...

8/2/2021Biopharma Companies Still Waiting for Clarity on China's New Patent Te...

8/1/2021NHSA Publicizes the List of Drugs Passing Form Evaluation for Inclusio...

7/30/2021Financial-related Company News in Brief (July 2021)

7/30/2021Recent Executive Moves

7/29/2021SMEI: Chinese Drug Market under Transformation with Growing ex-Hospita...

7/29/2021Junshi's Chinese sNDA for Toripalimab Plus Chemotherapy as First-Lin...

7/29/2021Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D a...

7/29/2021Complix Signs Global Drug R&D Pact with Nhwa Pharma to Develop Novel A...

7/29/2021I-Mab's Chinese IND for P2 Trial of Efineptakin Alfa in Combo with PD-...

7/29/2021Health Care in the Year of the Ox: Navigating China's Dynamic M&A Mark...

7/28/2021NHC Issues the Guidelines for Comprehensive Clinical Appraisal of Drug...

7/28/2021Daewoong Reports Positive Chinese Ph3 Trial Outcome of Its Botulinum...

7/27/2021NMPA Revises Packages Insert of Vitamin B6 Injection

7/27/2021NMPA Issues the Announcement on Certain Matters Related to Drug-Device...

7/27/2021HUTCHMED and AZ Initiate Phase II Trial of ORPATHYS for MET Amplified ...

7/27/2021NASDAQ-listed I-Mab to Seek Dual Listing on Shanghai's STAR Market

7/27/2021Sanofi Secures A New Indication for Renvela (sevelamer) in China

7/27/2021Understanding "Internet Plus Healthcare" in China: Policy Text Analysi...

7/23/2021Novartis Reports Strong H1 & Q2 Global and China Performance

7/23/2021Roche Reports Flat H1 Performance with Moderate China Drug Sales Growt...

7/23/2021Menarini AP Acquires China Rights of Cialis (Tadalafil) from Lilly

7/23/2021Recent Executive Moves

Page:85/357 Total number of articles:10681: [First][<<] [83] [84] [85] [86] [87] [>>] [End]